Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Tracing Technique Untangles Brain Circuit Networks

By BiotechDaily International staff writers
Posted on 09 Jul 2013
Image: Neurons in the basal ganglia (Photo courtesy of Anatol Kreitzer, PhD, Gladstone Institutes).
Image: Neurons in the basal ganglia (Photo courtesy of Anatol Kreitzer, PhD, Gladstone Institutes).
High-resolution mapping has uncovered the architecture of neural circuits leading to the basal ganglia, which could promote research into disorders such as Parkinson’s disease (PD) and Huntington’s disease.

Researchers at the Gladstone Institutes (San Francisco, CA, USA) and the Salk Institute (San Diego, CA, USA) combined mouse models with a sophisticated tracing technique, known as the monosynaptic rabies virus (MRV) system, to assemble brain-wide maps of the striatum of neurons that connect with the basal ganglia, integrating information from multiple brain regions to shape motor learning. The two major projection cell types in the striatum target different downstream basal ganglia targets and have opposing effects on motivated behavior, yet differential innervation of these neuronal subtypes is not well understood.

To examine whether input specificity provides a basis for information segregation, the researchers used a MRV system to generate brain-wide maps of neurons that form synapses with direct- or indirect-pathway striatal projection neurons. They found that sensory cortical and limbic structures mostly innervated the direct pathway, whereas motor cortex structures preferentially targeted the indirect pathway. The researchers also found that thalamostriatal input, dopaminergic input, and input from specific cortical layers were similar in both pathways. The study was published on June 26, 2013, in Neuron.

“Taming and harnessing the rabies virus is ingenious in the exquisite precision that it offers compared with previous methods, which were messier with a much lower resolution,” said study coauthor Anatol Kreitzer, PhD, of the Gladstone Institutes. “We took the approach one step further by activating the tracer genetically, which ensures that it is only turned on in specific neurons in the basal ganglia. This is a huge leap forward technologically, as we can be sure that we’re following only the networks that connect to particular kinds of cells in the basal ganglia.”

“These initial results should be treated as a resource not only for decoding how this network guides the vast array of very distinct brain functions, but also how dysfunctions in different parts of this network can lead to different neurological conditions,” added coauthor Edward Callaway, PhD, of the Salk Institute. “If we can use the rabies virus system to pinpoint distinct network disruptions in distinct types of disease, we could significantly improve our understanding of these diseases’ underlying molecular mechanisms and get even closer to developing solutions for them.”

The MRV system, originally developed in 2007 and refined by Dr. Callaway and other researchers for targeting specific cell types in 2010, uses a modified version of the rabies virus to “infect” a brain region, which in turn targets and infects neurons that are connected to it. When the system was applied in genetic mouse models, the team could see specifically how sensory, motor, and reward structures in the brain connected to medium spiny neurons (MSNs) in the basal ganglia.

Related Links:

Gladstone Institutes
Salk Institute



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.